Mixture of trypsin, chymotrypsin and papain reduces formation of metastases and extends survival time of C57Bl6 mice with syngeneic melanoma B16

Cancer Chemotherapy and Pharmacology, Supplement

Volumn 47, Issue 7, 2001, Pages

  Wald, M ^a   Olejar T ^a   Sebkova V ^a   Zadinova M ^a   Boubelik M ^a   Pouckova P ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

B16 melanoma; Metastasis; Papain; Trypsin

Indexed keywords

CHYMOTRYPSIN; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; PAPAIN; TRYPSIN; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ASCITES; CANCER INHIBITION; CANCER RECURRENCE; CANCER SURVIVAL; CANCER TRANSPLANTATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; MELANOMA; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE;

ADMINISTRATION, RECTAL; ANIMALS; ANTIGENS, CD44; ANTIGENS, SURFACE; ANTINEOPLASTIC AGENTS; CELL DIVISION; CHYMOTRYPSIN; DRUG COMBINATIONS; ENDOPEPTIDASES; FEMALE; IMMUNOGLOBULINS; INTERCELLULAR ADHESION MOLECULE-1; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; PAPAIN; TRYPSIN;

EID: 0034919719     PISSN: 09439404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (49)

1. Modulation of pulmonary metastasis (Lewis lung carcinoma) by bromelain, an extract of the pineapple stem
2. Intestinal absorption of undegraded proteins in men: Presence of bromelain in plasma after oral intake
3. Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases
4. Induction of tumor necrosis factor in human peripheral-blood mononuclear cells by proteolytic enzymes
5. Cytokine synthesis in human peripheral blood mononuclear cells after oral administration of polyenzyme preparations
6. Oral enzyme therapy improves remission time, soluble TNF receptors and α2-microglobulin concentration in chemotherapy treated multiple myeloma patients
7. Integrins and other adhesion molecules involved in melanocytic tumor progression
8. Bromelain proteinase F9 augments human lymphocyte-mediated growth inhibition of various tumor cells in vitro
9. Proteolytic enzymes modulate the adhesion molecule CD44 on malignant cells in vitro
10. Bromelain proteases suppress growth, invasion and lung metastasis of B16F10 mouse melanoma cells
11. Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8 and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation
12. Binding of transforming growth factor-beta 1 to methylamine-modified alpha 2-macroglobulin and to binary and ternary alpha 2-macroglobulin-proteinase complexes
13. Bromelain proteases modulate the CD44 expression on human MOLT 4/8 leukaemia and SK-Mel 28 melanoma cells in vitro
14. CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness
15. Evaluation of response rates to various antitumour agents of human gastric tumours implanted in nude mouse
16. Interactions between cytokines and α2-macroglobulin
17. Matrix metalloproteinases in skin
18. Proteinase-activated receptor-2-mediated signaling and inhibition of DNA synthesis in human pancreatic cancer cells
19. Neue Perspektiven in der Tumortherapie
20. Selective modulation of cell adhesion molecules on lymphocytes by bromelain protease 5
21. Oral bioavailability of proteolytic enzymes
22. Luminal trypsin may regulate enterocytes through proteinase activated receptor 2
23. Cytokine binding and clearance properties of proteinase activated α2-macroglobulin
24. An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice
25. Immunomodulation by proteolytic enzymes
26. (2-) mobilization in human T cell lines through interaction with different protease-activated receptors
27. High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer
28. Matrix metalloproteinases and their inhibitors in gastric cancer
29. CD44 is an independent prognostic factor in conventional renal cell carcinomas
30. The CD44 protein family
31. CD44 and the adhesion of neoplastic cells
32. Tumour-associated trypsin inhibitor, TATI. Clinical use and biological function
33. Potential of targeting cell surface CD44 proteins with proteinases in preventing tumor growth and metastasis
34. Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells
35. Prevention of murine EAE by oral hydrolytic enzyme treatment
36. Bromelain, the enzyme complex of pineapple and its clinical application, an update
37. Inhibition of tumour growth in vitro by bromelain, an extract of the pineapple plant (Ananas comosus)
38. Stromelysin-3 (ST-3): Immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumours and other skin disorders
39. Neutrophil apoptosis induced by proteolytic enzymes
40. Reaction of a tumour-associated trypsin inhibitor with serine proteinases associated with coagulation and tumour invasion
41. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value
42. Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma
43. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis
44. Thrombin and trypsin induce granulocyte-macrophage colony-stimulating factor and interleukin-6 gene expression in cultured normal human keratinocytes
45. Polyenzyme preparation Wobe-Mugos inhibits growth of solid tumors and development of experimental metastases in mice
46. 6 mice with Lewis lung carcinoma
47. The effect of proteinases on survival and certain haematological parameters in SD/Ipcv rats with spontaneous lymphoblastic leukaemia
48. Stimulation of reactive oxygen species production and cytotoxicity in human neutrophils in vitro and after oral administration of a polyenzyme preparation